Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
GURU Organic Energy's Amazon Canada Unit Sales Rise 51% During Prime Big Deal Days

GURU Organic Energy's Amazon Canada Unit Sales Rise 51% During Prime Big Deal Days

BitgetBitget2026/10/20 11:31
  • GURU Organic Energy’s Canadian Amazon unit sales rose 51% during Oct. 6-7, 2026, versus last year’s four-day Prime Big Deal Days.
  • U.S. unit sales increased 25%, marking a third consecutive event record. Sales volume has grown nearly 70% over two years.
  • Canadian unit sales on Oct. 6 exceeded the previous daily record by about 50%, more than doubling last year’s opening-day volume.
  • Zero Sugar products represented nearly half of Canadian units sold and about 40% of U.S. volume.
  • The Zero Variety Pack was the top seller in both markets. Zero Sugar drove most U.S. year-over-year unit growth.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GURU Organic Energy Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610200730PRIMZONEFULLFEED9849087) on October 20, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12